States tired of waiting for feds to tackle high drug prices | Washington Examiner

State legislatures are battling against high drug prices, tired of inaction from the federal government.

Last year, states passed more than double the number of laws attacking high drug prices than in 2016, and legislatures show no signs of stopping.

States approved 14 laws in 2017 targeting high drug prices through price transparency, compared to four in 2016, according to data from consulting firm PricewaterhouseCoopers Health Research Institute. State legislatures introduced 45 drug pricing transparency bills in 2017, compared to 38 in 2016.

Ten states introduced bills aimed at putting price controls on expensive drugs, with three of the bills passing and two pending. The remaining five bills failed. In 2016, nine price control bills were introduced but none passed, PricewaterhouseCoopers found.

Other laws have targeted price transparency in an effort to “name and shame” drugmakers for high prices. For instance, California now requires each drug manufacturer and wholesaler to notify purchasers of price hikes and must submit quarterly reports to states to justify any increases, Pew said.

Some states took unique approaches to price controls. New York included a provision in its 2018 budget that lets state officials set an annual projected spending target for prescription drugs under its Medicaid program.

Read complete article here:

States tired of waiting for feds to tackle high drug prices.